TELA Bio, Inc. (TELA) Misses Q2 EPS by 28c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts TELA Hot Sheet
Join SI Premium – FREE
TELA Bio, Inc. (NASDAQ: TELA) reported Q2 EPS of ($0.88), $0.28 worse than the analyst estimate of ($0.60). Revenue for the quarter came in at $10.4 million versus the consensus estimate of $10.12 million.
GUIDANCE:
TELA Bio, Inc. sees FY2022 revenue of $42-45 million, versus the consensus of $42.3 million.
For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- Avnet (AVT) Tops Q1 EPS by 97c ; Offers Guidance
- SelectQuote, Inc. (SLQT) Tops Q1 EPS by 13c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
